Opdivo (nivolumab) is a cancer medicine that is used alone or in combination with other medicines that works with your immune system to interfere with the growth and spread of cancer cells in the body.
Opdivo is used alone or in combination with other medicines to treat adults with:
advanced skin cancer (melanoma);
advanced non-small cell lung cancer;
pleural mesothelioma (cancer that affects the lining of the lungs and chest wall);
kidney cancer;
classical Hodgkin lymphoma;
cancer of the stomach and esophagus;
squamous cell cancer of the esophagus or head and neck;
bladder cancer;
liver cancer; or
colorectal cancer.
Opdivo is often given when the cancer has spread to other parts of the body (metastatic), or cannot be surgically removed, or has come back after prior treatment. Opdivo is sometimes given only if laboratory testing shows specific genetic markers or DNA mutations associated with your cancer.
